Clear Cell Renal Cell Carcinoma (ccRCC)
15 clinical trials · Condition
◉ Watch Clear Cell Renal Cell Carcinoma (ccRCC)
| Record | Firm | Date |
|---|---|---|
| Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors (NCT05176483) | Exelixis | 2021-12-14 |
| A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors (NCT03972657) | Regeneron Pharmaceuticals | 2019-08-12 |
| A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003) (NCT03634540) | Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2018-09-27 |
| Study CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC) (NCT02771626) | Calithera Biosciences, Inc | 2016-08-01 |
Track Clear Cell Renal Cell Carcinoma (ccRCC) automatically
Every clearance here is in the API, with alerts when new ones post.